CEimpact Podcast

A nurse was found guilty of gross neglect and negligent homicide in Tennessee. This case has been closely watched by medical professionals, because it may set a new precedent for criminalizing medical mistakes. Guests David Brushwood and Jake Galdo join the podcast to try and make sense of this sensational news.  The GameChanger: This case may change the way in which medical mistakes are handled i...

Reliever Inhaled Glucocorticoid Treatment Black and Latinx patients are disproportionately impacted by asthma. In fact, asthma mortality rates are twice as high in Black patients compared to White patients. Are there different treatment options to help improve mortality in these populations? Join host Geoff Wall with guest Dr. Matt Trump as they discuss the PREPARE trial. The GameChanger Emerging...

Septic shock is one of the most common causes of deaths in critically ill patients. The updated Surviving Sepsis Campaign Guidelines provide recommendations on the use of adjunct steroids in the treatment of sepsis. However, when to start corticosteroids is still unknown – or is it? This episode of GameChangers evaluates the timing of corticosteroid use in sepsis. The GameChanger Corticosteroids a...

Current guidelines do not recommend switching between different levothyroxine products due to concerns of potential changes in TSH levels. However, getting the same levothyroxine product every time may be difficult for patients due to financial or stocking constraints. Join your host, Geoff Wall, and guest, Dr. Jamie Pitlick to discuss a recent study that examined the consequences of switching bet...

Approximately 1 in 5 individuals in the United States alone will experience depression during their lifetime. Current guidelines suggest that monotherapy may be used as initial therapy for major depressive disorder, but what evidence exists suggesting that starting dual anti-depressant therapy may have better outcomes? Join your host, Geoff Wall as he discusses a recent meta-analysis regarding dua...

The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19. The GameChangers The use of high-dose famotidine in the treatment of COVID-19 has demonstrated moderate safety, but questionable efficacy. Additionally, a recent meta-analysis examining the efficacy of lockdown on the spread of...

Are you still using post-it notes, clips, and stickers to facilitate your Pharmacy's workflow? You aren't alone - many of us are using tactile tools to run our pharmacies. Even if you are leveraging technology, can you confidently say you are maximizing it?  We've come to the point that maximizing technology isn't a choice; it's necessary to save our profession. This episo...

Perhaps one of the greatest challenges a preceptor has is that of honestly evaluating poor performance in a way that will help get the student either back on track, or connected to the help and support they need, depending on the specific performance issue or issues they are exhibiting. It sounds cold, but in experiential education it has been said more often than once – that sometimes you just ha...

Routine exercise is gamechanging. In this epsiode, Geoff is joined by Keaton Higgins, pharmacy student and certified athletic trainer, to discuss the mortality benefits of regular exercise. Host Geoff Wall, PharmD., BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health Guest Keaton Higgins, ATC P3 University of Iowa Redeem your CPE or C...

Level Up: Is your pharmacy ready for the future and able to handle the present environment? Listen in to learn how you can strengthen the brick-and-mortar experience in your pharmacy and remain viable in an increasingly online world. In this episode, Dr. Ben McNabb pharmacist and owner at Love Oak Pharmacy discusses the current and future state of community pharmacy.  Oak Love Pharmacy is a local...

Direct to consumer marketing has been a GameChanger in recent years. As new drugs are approved and marketed, healthcare teams must stay ahead of the news and advertisements in order to educate patients and peers on the risks, benefits, and nuances that impact our patients and our practice. Tune into this special, extended 90-minute episode to catch up on recent medications impacting practice.   Ho...

Up to 69% of #Hospitalizations are caused by Medication Non-Adherence. Think of the impact pharmacists could make on the healthcare spend and patient outcomes if we could have a significant impact on that! Tooktake is a new medication reminder. This episode explores how you can offer a new, simple and inexpensive wellness tool to help your patients. It's a new medication reminder called “took...

Opioids are always in the news for adverse reactions and poor outcomes. Two opioids - tramadol and codeine - are often left out of the fey as potential alternatives. Yet, these medications are not without adverse events. A recent study evaluated the mortality and safety differences in tramadol and codeine. Redeem your CPE or CME credit here! Pharmacist members CME Need a membership? Join for CPE C...

Part 2 of this special two-part series takes a deep dive into the top clinical medicine and healthcare issues that have been true GameChangers this past year. Join us as Geoff Wall and Jake Galdo discuss the latest in practice trends, policy changes, guideline updates, new laws, and much more. Did you miss Part 1? If so, be sure to check out GameChangers Episode #308 for more important GameChanger...

It's easy to focus on the development of clinical skills in our pharmacy learners, but what is our responsibility as preceptors for their personal and professional development? Join us for this episode where Jake Galdo and Josh Kinsey share their thoughts on the importance of developing the whole student, and how this investment will positively impact pharmacy practice. We'll touch on ev...

Part 1 of this special two-part series takes a deep dive into the top clinical medicine and healthcare issues that have been true GameChangers in 2021. Join us as Geoff Wall and Jake Galdo discuss the latest in practice trends, policy changes, guideline updates, new laws, and much more. Show Segments: 01:38 – SGLT2 Inhibitors in Heart Failure 14:47 – Point of Care Testing 26:32 – Semaglutide for W...

Weight gain can impact patient’s quality of life and put them at risk for health complications. While weight loss can be an important factor in a patient’s health, it is equally important that it is done safely and effectively. Listen in as host, Geoff Wall compares the safety and efficacy of semaglutide and liraglutide in weight loss.  The GameChanger: Based on a recent Phase-3 study, semaglutide...

Every January, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover updates from diabetes advocacy to technology changes. Learn what changed and what matters most for individuals with diabetes. Time in range was introduced in the 2021 update and is becoming the standard of glycemic targets and control  Metformin may not be the first line option...

While HIV treatment has come a long way over the decades, it still faces challenges. Specifically, HIV therapy such as integrase inhibitors have been associated with increased weight gain but the mechanism and extent of which has remained largely unknown. Listen in as Dave Hachey, HIV expert, and Geoff Wall discuss this and how it impacts medication selection when caring for patients with HIV. The...

Failure is universal to the human experience. Grit, or the ability to demonstrate tenacity, perseverance, and resilience in the face of failure is a learned skill. Success requires both. Join us  in a conversation with Dr. Michael Rupp, failure "master", professor, preceptor, and student mentor. We'll discuss the value of failure, as well as the challenges and opportunities we face...

Studies show that opioids are the number one prescribed medication for peripheral neuropathy contrary to evidence suggesting a lack of efficacy. Despite being a common condition for individuals with diabetes, treatment is often non-evidence based, meaning that creating a care plan can be difficult. With this, the American Academy of Neuropathy (AAN) was urged to re-evaluate treatment recommendatio...

Two oral therapies for COVID-19 were recently approved. Listen in as we discuss who is eligible to receive them, their efficacy, and what this means for the future of COVID-19 treatment. Guest : Patrick Kinn, PharmD, MPH, BCPS Clinical Pharmacy Specialist - Infectious Disease University of Iowa Health Care John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake) Course Content and Developer, CEimpact Pharmac...

The FDA recently approved the first eyedrop to treat age-related nearsightness due to poor accommodation, a disorder experienced by more than 100 million Americans. Spoiler alert . . . its pilocarpine eye drops -  which have been on the market for over 70 years.  What does the data say about this new formulation of an old drug and its ability to help with age-related presbyopia? Listen in for a di...

Pain is not a game. Chronic non-malignant pain has few effective treatment options, particularly since the adverse effects of opioids have become more known. Many patients with chronic pain also develop mental health issues such as depression and anxiety.  A new virtual reality system, designed for at-home self-use, has been approved by the FDA to treat chronic low back pain in adults.  Dr. John S...

Since the REDUCE study was published in 2013, most guidelines recommend a standard dose of prednisone 40mg for 5 days (or an equivalent dose of another steroid). However, the optimal dose of steroids may be different depending on patient factors. Tune in to explore the concept of personalizing steroid doses in AECOPD using a dosing scale. Redeem your CPE or CME credit here! Pharmacist members CME...